Please login to the form below

Not currently logged in
Email:
Password:

Ogilvy Commonhealth Worldwide open Moscow offices

Will focus on pharmaceutical and healthcare market in Russia

Ogilvey Commonhealth Worldwide has launched a new Moscow branch, which will form part of Ogilvy Group Russia.

The agency will provide the pharmaceutical and healthcare market with services including market access, OTC and Rx portfolio management, marketing, patient/HCP/pharmacy insight, advertising, media planning, medical education and digital communications.

The New Jersey, US-headquartered communications agency has appointed Dr Ekaterina Vaganova as managing director of the new Moscow offices.

As a graduate of Warsaw Medical Academy in Poland, Vaganova's professional career began with PwC Poland, where she was involved in supporting the Glaxo Wellcome and SmithKline Beecham merger.

In 2004 she returned to Russia and joined Publicis Group Russia, where she led and developed the communications agency's pharmaceutical business unit.

"Health has always been a key human value. That's why emphasising the importance of health-related products for our customers is a priority for us. We've built a first-class professional team - doctors, strategic planners, creatives and skilled communications managers - to deliver for our clients," Vaganova said.

Commenting on the launch, Ogilvy Commonhealth Worldwide president, Gloria Gibbons, said: "Now, with the changing market needs in Russia, we believe the Ogilvy Commonhealth offer is just what the healthcare sector needs here. And Ekaterina is the best person to lead this exciting challenge."

14th March 2013

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics